KINERET
As listed in the register: KINERET 100 mg/0,67 mL, solution injectable en seringue préremplie
100 mg · solution injectable
- Prescription only
- Active substance
- Anakinra
- Made by
- SWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Kineret). It describes the substance, not this exact product.
KINERET blocks the biologic activity of IL-1 alpha and beta by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.
IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-04-03
Safety of the active substance
From the US prescribing label for the same active substance (Kineret). It describes the substance, not this exact product.
- KINERET is contraindicated in patients with known hypersensitivity to E coli -derived proteins, KINERET, or any components of the product [see Hypersensitivity Reactions ( 5.3 )].
- Known hypersensitivity to E coli -derived proteins, Kineret, or to any component of the product.
The most common reason for withdrawing from studies.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE) |
|---|---|
| Active substance | Anakinra |
| Strength | 100 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services PEDIATRIE · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services PNEUMOLOGIE · prescription réservée aux spécialistes et services RHUMATOLOGIE · prescription réservée aux spécialistes et services ANESTHESIE-REANIMATION · prescription réservée aux spécialistes et services DERMATOLOGIE · liste I · prescription réservée aux spécialistes en MEDECINE INTENSIVE-REANIMATION · prescription réservée aux spécialistes en MEDECINE D'URGENCE · prescription réservée aux spécialistes en MALADIES INFECTIEUSES ET TROPICALES |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/02/203 |
| Name in the register | KINERET 100 mg/0,67 mL, solution injectable en seringue préremplie |
| Packs | 7 seringue(s) préremplie(s) en verre de 0,67 ml |
| CIS | 60663231 |
| CIP13 | 3400927732034 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).